Skip to main content

NanoVibronix, Inc. (NAOV) Stock Forecast 2025 - AI Price Prediction & Analysis


NanoVibronix, Inc. (NAOV) AI Stock Price Forecast & Investment Analysis

NanoVibronix, Inc. Stock Price Chart and Technical Analysis

Loading NanoVibronix, Inc. interactive price chart and technical analysis...

NanoVibronix, Inc. (NAOV) - Comprehensive Stock Analysis & Investment Research

Deep dive into NanoVibronix, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about NanoVibronix, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For NanoVibronix, Inc.: NanoVibronix, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

NanoVibronix, Inc. (Stock Symbol: NAOV) is a leading company in the Industrial Applications and Services sector , specifically operating within the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

The organization employs approximately 8 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing NanoVibronix, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NanoVibronix, Inc.: With $2M in annual revenue and 2172.4% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $2 million generating a 2172.4% net profit margin .

Market Capitalization: $4 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -218.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for NanoVibronix, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For NanoVibronix, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for NanoVibronix, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: NanoVibronix, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For NanoVibronix, Inc.: Market positioning analysis based on available financial and operational metrics.

NanoVibronix, Inc. strategically competes in the highly dynamic Orthopedic, Prosthetic & Surgical Appliances & Supplies marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 65.5% gross margin, indicating strong pricing power and operational efficiency.

NanoVibronix, Inc. (NAOV) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for NanoVibronix, Inc. stock analysis.

Loading NanoVibronix, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into NanoVibronix, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if NanoVibronix, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For NanoVibronix, Inc.: With a P/E ratio of -0.54, the market sees the stock as potentially undervalued.

P/E Ratio -0.54x
P/B Ratio 0.10x
Market Cap $4M
EPS $-15.68
Book Value/Share $51.44
Revenue/Share $2.97
FCF/Share $-0.42
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently NanoVibronix, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NanoVibronix, Inc.: An ROE of -218.6% indicates room for improvement in shareholder value creation.

ROE -218.6%
ROA -129.1%
ROIC -217.3%
Gross Margin 65.5%
Operating Margin -1072.4%
Net Margin 2172.4%
EBT Margin -562.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess NanoVibronix, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For NanoVibronix, Inc.: A current ratio of 3.68 indicates strong liquidity.

Current Ratio 3.68x
Quick Ratio 3.51x
D/E Ratio 0.01x
Financial Leverage 1.46x
Interest Coverage -528.4x
Working Capital $5M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal NanoVibronix, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For NanoVibronix, Inc.: Free cash flow of $-5M indicates cash challenges that need attention.

Operating Cash Flow $-5M
Free Cash Flow $-5M
FCF/Sales -276.6%
CapEx/Sales 0.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively NanoVibronix, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For NanoVibronix, Inc.: An asset turnover of 0.23x suggests room for improvement in asset utilization.

Asset Turnover 0.23x
Receivables Turnover 23.3x
Inventory Turnover 4.0x
Fixed Assets Turnover 47.2x
Days Sales Outstanding 16 days
Days Inventory 90 days
Payables Period 390 days
Cash Conversion Cycle -284 days
Understanding Financial Statement Data

What these metrics mean: Key figures from NanoVibronix, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For NanoVibronix, Inc.: With annual revenue of $2M, NanoVibronix, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $2M
Operating Income $1M
Net Income $-2M
R&D Expense $0M
SG&A Expense $321M
Cost of Goods Sold $0M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 96%
Cash & Short-term Investments 78%
Total Liabilities 31%
Short-term Debt 639%
Accounts Receivable 14%
Inventory 5%
Dividend & Shareholder Information
Shares Outstanding 1M
Growth Metrics (YoY)
EPS Growth -180.0%

Latest NanoVibronix, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting NanoVibronix, Inc. (NAOV) stock price and investment outlook.

, source: Yahoo Finance

TYLER, Texas, June 26, 2025--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the ...

, source: Yahoo Finance

TYLER, Texas, May 16, 2025--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in therapeutic devices, today announced the closing of its ...

, source: Yahoo Finance

As of 9:59:02 a.m. GMT+2. Market Open. TYLER, Texas, June 24, 2025--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive ...

, source: Yahoo Finance

TYLER, Texas, June 26, 2025--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the ...

, source: Yahoo Finance

TYLER, Texas, June 11, 2025--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in therapeutic devices, announced today, through its ENvue ...

NanoVibronix, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of NanoVibronix, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALGN Unlock Forecast - 30 Days FREE Trial $9935M 22.7x 2.5x
APT Unlock Forecast - 30 Days FREE Trial $51M 14.4x 0.8x
AVNS Unlock Forecast - 30 Days FREE Trial $589M 100.0x 0.8x
AVR Unlock Forecast - 30 Days FREE Trial $148M x 6.1x
BBLG Unlock Forecast - 30 Days FREE Trial $9M -0.6x 3.2x
BBLGW Unlock Forecast - 30 Days FREE Trial $49M -9.0x 16.9x
CDRE Unlock Forecast - 30 Days FREE Trial $1325M 34.8x 4.0x
CLGN Unlock Forecast - 30 Days FREE Trial $35M x 2.8x
COCH Unlock Forecast - 30 Days FREE Trial $7M -4.5x -0.3x
COCHW Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
ENOV Unlock Forecast - 30 Days FREE Trial $1789M -23.9x 0.7x
ESTA Unlock Forecast - 30 Days FREE Trial $1108M -15.4x 48.7x
EW Unlock Forecast - 30 Days FREE Trial $46128M 11.1x 4.4x
HSCS Unlock Forecast - 30 Days FREE Trial $3M -0.3x 0.7x
HSCSW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
INGN Unlock Forecast - 30 Days FREE Trial $219M -2.8x 1.1x
ISRG Unlock Forecast - 30 Days FREE Trial $167111M 64.1x 9.4x
LAKE Unlock Forecast - 30 Days FREE Trial $143M 742.3x 1.0x
LFWD Unlock Forecast - 30 Days FREE Trial $8M -2.5x 0.6x
LGMK Unlock Forecast - 30 Days FREE Trial $3M -0.3x 0.1x
MLSS Unlock Forecast - 30 Days FREE Trial $49M -7.1x 14.6x
MNESP Unlock Forecast - 30 Days FREE Trial $M x x
MSA Unlock Forecast - 30 Days FREE Trial $6875M 25.8x 8.4x
MYO Unlock Forecast - 30 Days FREE Trial $41M -26.3x 2.4x
NAOV Unlock Forecast - 30 Days FREE Trial $4M -0.5x 0.1x
NTRB Unlock Forecast - 30 Days FREE Trial $90M -5.1x 17.7x
NTRBW Unlock Forecast - 30 Days FREE Trial $26M -2.3x 5.2x
POAI Unlock Forecast - 30 Days FREE Trial $9M -2.5x -48.4x
RBOT Unlock Forecast - 30 Days FREE Trial $34M -4.2x 1.5x
SMTI Unlock Forecast - 30 Days FREE Trial $299M -37.5x 8.4x
SPAI Unlock Forecast - 30 Days FREE Trial $104M x 40.4x
STE Unlock Forecast - 30 Days FREE Trial $24986M 38.6x 3.6x
ZBH Unlock Forecast - 30 Days FREE Trial $20763M 25.2x 1.7x

Frequently Asked Questions - NanoVibronix, Inc. Stock Forecast

How accurate are NanoVibronix, Inc. stock predictions?

Our AI model demonstrates 29% historical accuracy for NAOV predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence NanoVibronix, Inc. stock price forecasts?

Our analysis considers NanoVibronix, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is NanoVibronix, Inc. a good investment in 2025?

Based on our AI analysis, NanoVibronix, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are NanoVibronix, Inc. forecasts updated?

NanoVibronix, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced NanoVibronix, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for NanoVibronix, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...